The latest from CDMOs, CMOs, and suppliers featuring Phlow, Evotec and Eversana.  

Chemicals/Chemical API Manufacturing 
* Phlow Expands Analytical Capabilities, Advances AI in Mfg 
General 
* Evotec Provides Update to Strategic Plan 
* Eversana Opens New Distribution Center

---

Chemicals/Chemical API Manufacturing 

Phlow Expands Analytical Capabilities, Advances AI in Mfg 
Phlow, a Richmond, Virginia-based CDMO of small molecules, has announced an expansion in its analytical capabilities and advances in the use of  artificial intelligence (AI) in its operations.  

Phlow has expanded its analytical laboratories in Richmond, Virginia, adjacent to its existing process research and development lab, to include additional capabilities for advanced spectroscopy tools and high-resolution, high-mass accuracy mass spectrometry. Phlow’s expanded laboratory space now offers analytical services for drug assays, impurity characterization and control, purity analysis, and process optimization for technologies such as continuous flow chemistry. 

Additionally, Phlow says it continues to invest in its cGMP kilo-scale and metric-ton scale manufacturing infrastructure in Petersburg, Virginia, and has selected the technology solutions provider, Apprentice, to provide an AI-driven manufacturing execution system.  

Source: Phlow 

---

General

Evotec Provides Update to Strategic Plan 
Evotec, a provider of drug-discovery, development and manufacturing services and a drug developer, has provided an update to its strategic plan following a review by the company.  

The company says it will focus on two key pillars: (1) drug discovery and preclinical development (collectively called Shared R&D) and (2) Just – Evotec Biologics, which provides contract biomanufacturing services, including for continuous biomanufacturing. It will also streamline by approximately 30% its asset portfolio, which includes pipeline assets that it co-owns with bio/pharmaceutical companies as well as assets to be partnered,.  

Last November (November 2024), Evotec announced the sale of its chemical active pharmaceutical ingredient (API) manufacturing site, Evotec DS GmbH, located in Halle/Westphalia, Germany, to Monacum Partners GmbH, a Munich, Germany-based private equity firm. This transaction formed part of the company’s“Priority Reset” initiative launched in April 2024, which aims to foster profitable growth by refining the company’s operational footprint and focusing on its primary growth sectors and core competencies. 

The company said that through its initiatives announced this month (April 2025), the company expects to deliver EUR 50 million ($57 million) in gross savings by 2028 on top of EUR 40 million ($46 million) from its Priority Reset initiative.  

Source: Evotec 

---

Eversana Opens New Distribution Center 
Eversana, a Chicago, Illinois-based third-party logistics (3PL) provider to the life-sciences industry, has opened a new 358,000-square-foot, cGDP-certified distribution center adjacent to its current campus in Memphis, Tennessee.  

The new facility adds 35% more operational controlled room temperature capacity across all sites and brings the company’s total 3PL footprint to more than 1.25 million square feet. The new facility also includes a new warehouse management system and AI-enabled warehouse automation robots. The company is also increasing its cold-chain capabilities with an additional 30,000 square feet of refrigerated and frozen storage capacity. 

Source: Eversana